{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:37:08Z","timestamp":1791387428756,"version":"4.3.3"},"reference-count":13,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ajem.2018.08.016","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T22:31:53Z","timestamp":1533681113000},"page":"2054-2057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pyelonephritis treatment in the community emergency department: Cephalosporins vs. first-line agents"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4584-8673","authenticated-orcid":false,"given":"Shaylyn","family":"Vogler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Pavich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2018.08.016_bb0005","unstructured":"Colgan R, Williams M and Johnson J. American family physician. Diagnosis and Treatment of Acute Pyelonephritis in Women Available at: http:\/\/www.aafp.org\/afp\/2011\/0901\/p519.html. (Accessed August 3, 2017)."},{"issue":"5","key":"10.1016\/j.ajem.2018.08.016_bb0010","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ajem.2018.08.016_bb0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/003655401750173922","article-title":"Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime","volume":"33","author":"Cronberg","year":"2001","journal-title":"Scand J Infect Dis"},{"issue":"9","key":"10.1016\/j.ajem.2018.08.016_bb0020","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3201\/eid2209.160148","article-title":"Fluoroquinolone-resistant and extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli infections in patients with pyelonephritis, United States","volume":"22","author":"Talan","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajem.2018.08.016_bb0025","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1086\/592250","article-title":"Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis","volume":"47","author":"Talan","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ajem.2018.08.016_bb0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2310\/8000.2012.120666","article-title":"Antibiotic resistance in isolates recovered from women with community-acquired urinary tract infections presenting to a tertiary care emergency department","volume":"14","author":"Filiatrault","year":"2012","journal-title":"CJEM"},{"issue":"11","key":"10.1016\/j.ajem.2018.08.016_bb0035","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/375078","article-title":"Fluoroquinolone-associated tendinopathy: a critical review of the literature","volume":"36","author":"Kaliq","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ajem.2018.08.016_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000334441","article-title":"QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications","volume":"120","author":"Briasoulis","year":"2011","journal-title":"Cardiology"},{"issue":"9","key":"10.1016\/j.ajem.2018.08.016_bb0045","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for clostridium difficile\u2013associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ajem.2018.08.016_bb0050","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/jac\/dks030","article-title":"Acute kidney injury associated with trimethoprim\/sulfamethoxazole","volume":"67","author":"Fraser","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajem.2018.08.016_bb0055","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/jac\/dkr159","article-title":"Hepatic safety of antibiotics used in primary care","volume":"66","author":"Andrade","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"16","key":"10.1016\/j.ajem.2018.08.016_bb0060","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1503\/cmaj.111152","article-title":"Considerations when prescribing trimethoprim-sulfamethoxazole","volume":"183","author":"Ho","year":"2011","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.ajem.2018.08.016_bb0065","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaci.2014.07.062","article-title":"Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis","volume":"135","author":"Macy","year":"2015","journal-title":"J Allergy Clin Immunol"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675718306521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675718306521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:42:47Z","timestamp":1760024567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675718306521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0735675718306521"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2018.08.016","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyelonephritis treatment in the community emergency department: Cephalosporins vs. first-line agents","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2018.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}